Published in Br J Pharmacol on January 01, 2013
Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis. Ann Rheum Dis (2014) 0.88
Identification of rheumatoid arthritis and osteoarthritis patients by transcriptome-based rule set generation. Arthritis Res Ther (2014) 0.82
Affinity maturation of a novel antagonistic human monoclonal antibody with a long VH CDR3 targeting the Class A GPCR formyl-peptide receptor 1. MAbs (2015) 0.79
Quantitative measurement of the target-mediated internalization kinetics of biopharmaceuticals. Pharm Res (2014) 0.78
Some quantitative uses of drug antagonists. Br J Pharmacol Chemother (1959) 41.90
Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol (2010) 17.30
Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol (2010) 13.76
pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res (1990) 12.75
Role of cytokines in rheumatoid arthritis. Annu Rev Immunol (1996) 10.22
Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nat Biotechnol (1996) 4.45
Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Cochrane Database Syst Rev (2009) 2.61
Selection of phage antibodies by binding affinity. Mimicking affinity maturation. J Mol Biol (1992) 2.50
Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator. Arthritis Rheum (2003) 2.47
The role of tyrosine kinase activity in endocytosis, compartmentation, and down-regulation of the epidermal growth factor receptor. J Biol Chem (1991) 2.15
Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site. J Mol Biol (1996) 2.08
Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis. Nat Rev Rheumatol (2009) 2.06
Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis (1993) 2.01
In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity. Proc Natl Acad Sci U S A (1994) 1.93
CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range. J Mol Biol (1995) 1.90
Synovial fluid from patients with rheumatoid arthritis inhibits neutrophil apoptosis: role of adenosine and proinflammatory cytokines. Rheumatology (Oxford) (2002) 1.82
Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome. Best Pract Res Clin Rheumatol (2002) 1.79
Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease. Arthritis Res (2001) 1.66
Sym004: a novel synergistic anti-epidermal growth factor receptor antibody mixture with superior anticancer efficacy. Cancer Res (2010) 1.59
An integrated vector system for the eukaryotic expression of antibodies or their fragments after selection from phage display libraries. Gene (1997) 1.50
The Schild regression in the process of receptor classification. Can J Physiol Pharmacol (1982) 1.46
Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways. J Immunol (1999) 1.38
Associations of disease activity and treatments with mortality in men with rheumatoid arthritis: results from the VARA registry. Rheumatology (Oxford) (2010) 1.25
Probing a protein-protein interaction by in vitro evolution. Proc Natl Acad Sci U S A (2006) 1.15
Selection and rapid purification of murine antibody fragments that bind a transition-state analog by phage display. Appl Biochem Biotechnol (1994) 1.07
Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor-α, in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human study. Ann Rheum Dis (2011) 1.06
Receptor clearance obscures the magnitude of granulocyte-macrophage colony-stimulating factor responses in mice to endotoxin or local infections. Blood (1999) 1.03
Specific human granulocyte-macrophage colony-stimulating factor antagonists. Proc Natl Acad Sci U S A (1994) 1.00
Cellular processing of murine colony-stimulating factor (Multi-CSF, GM-CSF, G-CSF) receptors by normal hemopoietic cells and cell lines. Growth Factors (1988) 0.97
GM-CSF neutralisation suppresses inflammation and protects cartilage in acute streptococcal cell wall arthritis of mice. Ann Rheum Dis (2006) 0.96
Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity. J Mol Biol (1996) 0.96
Measurement of colony-stimulating factors in synovial fluid: potential clinical value. Rheumatol Int (1995) 0.91
Internalisation and recycling of the granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor on a murine myelomonocytic leukemia. J Cell Physiol (1987) 0.87
A gene map of the human genome. Science (1996) 14.32
A physical map of 30,000 human genes. Science (1998) 12.43
Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature (2000) 10.04
A receptor kinase-like protein encoded by the rice disease resistance gene, Xa21. Science (1995) 9.79
Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature (1985) 9.62
Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell (1997) 8.72
Regulation of RAD53 by the ATM-like kinases MEC1 and TEL1 in yeast cell cycle checkpoint pathways. Science (1996) 8.71
The Newcastle exercise project: a randomised controlled trial of methods to promote physical activity in primary care. BMJ (1999) 8.16
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum (1996) 6.88
Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ (2000) 6.67
Following a diabetogenic T cell from genesis through pathogenesis. Cell (1993) 6.46
Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J Virol (1999) 4.99
Drosophila Rho-associated kinase (Drok) links Frizzled-mediated planar cell polarity signaling to the actin cytoskeleton. Cell (2001) 3.65
The role of working memory in visual selective attention. Science (2001) 3.54
A diverse new primate fauna from middle Eocene fissure-fillings in southeastern China. Nature (1994) 3.46
Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med (1995) 3.40
A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity. Cell (1999) 3.36
Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-beta signaling. J Biol Chem (2000) 3.12
Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation. Nat Cell Biol (2000) 3.09
Nonlinear event-related responses in fMRI. Magn Reson Med (1998) 3.09
The physiological basis of attentional modulation in extrastriate visual areas. Nat Neurosci (1999) 3.04
Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology (1998) 3.03
Neural correlates of perceptual rivalry in the human brain. Science (1998) 3.01
Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost (2006) 2.99
Screening for depression: single question versus GDS. J Am Geriatr Soc (1994) 2.79
Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor. J Lipid Res (1980) 2.63
Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol (2001) 2.56
Status of nonoperative management of blunt hepatic injuries in 1995: a multicenter experience with 404 patients. J Trauma (1996) 2.53
Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc Natl Acad Sci U S A (1996) 2.53
Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia. J Infect Dis (2012) 2.52
Characterizing stimulus-response functions using nonlinear regressors in parametric fMRI experiments. Neuroimage (1998) 2.51
Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha /beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells. Proc Natl Acad Sci U S A (2001) 2.46
Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins. Biotechnology (N Y) (1995) 2.45
Barriers to physical activity and socioeconomic position: implications for health promotion. J Epidemiol Community Health (1999) 2.39
Nuclear trafficking of Cubitus interruptus in the transcriptional regulation of Hedgehog target gene expression. Cell (1999) 2.34
GATAAG; a cis-control region binding an erythroid-specific nuclear factor with a role in globin and non-globin gene expression. Nucleic Acids Res (1989) 2.31
Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation. J Virol (1995) 2.29
Unbinding forces of single antibody-antigen complexes correlate with their thermal dissociation rates. Proc Natl Acad Sci U S A (2000) 2.27
Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res (2001) 2.27
Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway. Nat Cell Biol (2001) 2.25
Diffusion-weighted MR imaging: diagnostic accuracy in patients imaged within 6 hours of stroke symptom onset. Radiology (1999) 2.21
Human enhancer of filamentation 1, a novel p130cas-like docking protein, associates with focal adhesion kinase and induces pseudohyphal growth in Saccharomyces cerevisiae. Mol Cell Biol (1996) 2.12
Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat Med (1997) 2.12
Severe colitis in mice with aberrant thymic selection. Immunity (1995) 2.11
Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis. Euro Surveill (2006) 2.08
14-3-3zeta binds a phosphorylated Raf peptide and an unphosphorylated peptide via its conserved amphipathic groove. J Biol Chem (1998) 2.07
Effect of obesity on flap and donor-site complications in free transverse rectus abdominis myocutaneous flap breast reconstruction. Plast Reconstr Surg (2000) 2.06
Ethical debate. Too drunk to care? BMJ (1998) 2.05
Hepatitis G virus in long-term survivors of haematological malignancy. Lancet (1996) 2.05
Sonic hedgehog protein signals not as a hydrolytic enzyme but as an apparent ligand for patched. Proc Natl Acad Sci U S A (1999) 2.04
A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). Ann Oncol (1994) 2.02
E-cadherin regulates the function of the EphA2 receptor tyrosine kinase. Cell Growth Differ (1999) 2.01
Targeted disruption of the ubiquitous CNC-bZIP transcription factor, Nrf-1, results in anemia and embryonic lethality in mice. EMBO J (1998) 1.97
Streptolysin O and adherence synergistically modulate proinflammatory responses of keratinocytes to group A streptococci. Mol Microbiol (1998) 1.96
Time course of lesion development in patients with acute stroke: serial diffusion- and hemodynamic-weighted magnetic resonance imaging. Stroke (1998) 1.96
Interaction between yeast Cdc6 protein and B-type cyclin/Cdc28 kinases. Mol Biol Cell (1996) 1.94
Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing. J Thromb Haemost (2014) 1.90
False-positive coding for acute myocardial infarction on hospital discharge records: chart audit results from a tertiary centre. Can J Cardiol (1990) 1.87
Online social network size is reflected in human brain structure. Proc Biol Sci (2011) 1.87
The internet. J Neurol Neurosurg Psychiatry (2002) 1.86
Effective and efficient platelet transfusion strategies that maintain hemostatic protection. Transfusion (1998) 1.86
beta(2)-adrenergic receptor overexpression exacerbates development of heart failure after aortic stenosis. Circulation (2000) 1.83
Neural correlates of change detection and change blindness. Nat Neurosci (2001) 1.82
Isolation of a highly specific ligand for the alpha 5 beta 1 integrin from a phage display library. J Cell Biol (1994) 1.80
Protein kinase A antagonizes Hedgehog signaling by regulating both the activator and repressor forms of Cubitus interruptus. Genes Dev (1999) 1.79
Upregulation of PIP3-dependent Rac exchanger 1 (P-Rex1) promotes prostate cancer metastasis. Oncogene (2009) 1.76
Evaluating RECONSIDER. A computer program for diagnostic prompting. J Med Syst (1985) 1.75
Interactions with Costal2 and suppressor of fused regulate nuclear translocation and activity of cubitus interruptus. Genes Dev (2000) 1.75
Aortic aneurysm: a multifocal disease. Presidential address. Arch Surg (1982) 1.74
Developmental control point in induction of thymic cortex regulated by a subpopulation of prothymocytes. Nature (1995) 1.71
ENCORE: the effect of nutrient enrichment on coral reefs. Synthesis of results and conclusions. Mar Pollut Bull (2001) 1.69
Ribosome display efficiently selects and evolves high-affinity antibodies in vitro from immune libraries. Proc Natl Acad Sci U S A (1998) 1.69
A specific role for the thalamus in mediating the interaction of attention and arousal in humans. J Neurosci (1998) 1.68
Identification and characterization of the CXCR4 chemokine receptor in human T cell lines: ligand binding, biological activity, and HIV-1 infectivity. J Immunol (1998) 1.67
Impact of opportunistic diseases on chronic mortality in HIV-infected adults in Côte d'Ivoire. S Afr Med J (2006) 1.67
CTF determination of images of ice-embedded single particles using a graphics interface. J Struct Biol (1996) 1.65
Genetic diversity in the northernmost Oryza rufipogon populations estimated by SSR markers. Theor Appl Genet (2003) 1.65
Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules. Proc Natl Acad Sci U S A (1996) 1.62
Hyporesponsiveness in contact hypersensitivity and irritant contact dermatitis in CD4 gene targeted mouse. J Invest Dermatol (1996) 1.62
Stepwise development of thymic microenvironments in vivo is regulated by thymocyte subsets. Development (2000) 1.62
The effect of timing of ondansetron administration on its efficacy, cost-effectiveness, and cost-benefit as a prophylactic antiemetic in the ambulatory setting. Anesth Analg (1998) 1.60
Continuous ambulatory peritoneal dialysis in systemic amyloidosis and end-stage renal disease. J R Soc Med (1984) 1.60
Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology (2001) 1.59
Antiviral and lung protective activity of a novel respiratory syncytial virus fusion inhibitor in a mouse model. Eur Respir J (2010) 1.59
On the nature of the "non-saturable" migration of amino acids into Ehrlich cells and into rat jejunum. Bibl Laeger (1966) 1.59
Sound alters activity in human V1 in association with illusory visual perception. Neuroimage (2006) 1.59
Von Willebrand factor--cleaving protease activity in congenital thrombotic thrombocytopenic purpura. Br J Haematol (2000) 1.58
Physical characteristics and ventilatory function of 404 commercial divers working in the North Sea. Br J Ind Med (1977) 1.58
An Eph receptor regulates integrin activity through R-Ras. Proc Natl Acad Sci U S A (1999) 1.57
An extreme-sib-pair genome scan for genes regulating blood pressure. Am J Hum Genet (1999) 1.56
Thymus: a direct target tissue in graft-versus-host reaction after allogeneic bone marrow transplantation that results in abrogation of induction of self-tolerance. Proc Natl Acad Sci U S A (1990) 1.56
Fractal morphology, imaging and mass spectrometry of single aerosol particles in flight. Nature (2012) 1.56
Cryptotomography: reconstructing 3D Fourier intensities from randomly oriented single-shot diffraction patterns. Phys Rev Lett (2010) 1.55
Molecular detection of bacterial DNA in venereal-associated arthritis. Arthritis Rheum (1996) 1.55
Absence of natural killer cells during murine pregnancy is associated with reproductive compromise in TgE26 mice. Biol Reprod (1997) 1.55
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia (2012) 1.55
In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J Immunol (1997) 1.53
Roentgenograms in primary care patients with acute low back pain: a cost-effectiveness analysis. Arch Intern Med (1982) 1.53
Two novel mutations of the nicastrin gene in Chinese patients with acne inversa. Br J Dermatol (2011) 1.53